Clinical Trials

Is Triple Therapy a Game Changer for BRAF V600E-Mutant mCRC Patients?
Research & Development Is Triple Therapy a Game Changer for BRAF V600E-Mutant mCRC Patients?

The quest for improved treatment options for metastatic colorectal cancer (mCRC) patients with the BRAF V600E mutation has always been fraught with challenges. Given the aggressive nature of these tumors and the historically poor prognosis associated with this genetic mutation, researchers have

Are Anatomic Lung Resections Superior for Stage 1A NSCLC Survival?
Research & Development Are Anatomic Lung Resections Superior for Stage 1A NSCLC Survival?

Recent research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting has shed light on the survival benefits of anatomic lung resections, specifically lobectomy and segmentectomy, for patients diagnosed with stage 1A non-small cell lung cancer (NSCLC). Utilizing data from the STS

Is There a Link Between Endometriosis and Cardiovascular Disease Risk?
Research & Development Is There a Link Between Endometriosis and Cardiovascular Disease Risk?

Endometriosis is a condition characterized by the abnormal growth of endometrium-like tissue outside of the uterus. These growths, which often attach to pelvic organs such as the ovaries, fallopian tubes, bladder, and intestines, undergo the same cycle of thickening, breaking down, and bleeding as

Can IL-33 Pathway Revolutionize Immunotherapy in Pancreatic Cancer?
Research & Development Can IL-33 Pathway Revolutionize Immunotherapy in Pancreatic Cancer?

Recent advancements in cancer research have brought to light exciting new possibilities in the realm of immunotherapy, particularly concerning pancreatic cancer. Led by Dr. Vinod Balachandran, a team at Memorial Sloan Kettering Cancer Center (MSK) has made groundbreaking discoveries related to the

AI's Impact on Drug Development: Unseen Challenges and Limited Success
Research & Development AI's Impact on Drug Development: Unseen Challenges and Limited Success

The transformative potential of Artificial Intelligence (AI) in the field of therapeutics, particularly drug development, has been a topic of significant excitement and investment. However, despite the enthusiasm, tangible evidence of AI's success in revolutionizing drug development remains

Revolutionizing Clinical Trials: The Power of Digital Adherence Tools
Research & Development Revolutionizing Clinical Trials: The Power of Digital Adherence Tools

Clinical trials are the backbone of medical advancements, but they face a persistent challenge: participant adherence. Non-adherence can skew results, impact outcomes, and undermine the effectiveness of health solutions. Enter digital adherence tools, which are revolutionizing the landscape by

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later